As a leading vaccine company, Crucell focuses on developing, producing and marketing vaccines against a wide variety of infectious diseases applying a broad portfolio of technologies in order to meet the specific demands posed by the different pathogens including viruses, parasites and bacteria.

Crucell’s main vaccine technologies include:

• PER.C6^® Technology
• AdVac^® Technology
• Virosome Technology
• Recombinant Paramyxovirus Technology
• Hansenula polymorpha Technology